The Serum Institute of India (SII) is legally compelled to ship coronavirus vaccine to global vaccine sharing facility Covax, its co-lead, the Global Alliance for Vaccines and Immunisation (Gavi), told Reuters, a provision that could complicate the firm’s efforts to boost domestic supplies.
“The agreement is legally binding and served as a basis for the first-round allocation document, which has been communicated to all participating economies,” a Gavi spokeswoman said in an email.
“SII has pledged that, alongside supplying India, it will prioritise the Covax multilateral solution for equitable distribution.”
